Agenda

Wednesday October 5

7:00 a.m.

Registration

8:00 - 10:15 a.m.

Session IV: Translating Stem Cell Biology Toward Therapy
Moderator: George Q. Daley, M.D., Ph.D.
                 Children's Hospital Boston and Harvard Medical School

Stromal Dynamics
David T. Scadden, M.D.external link icon
Harvard University and Massachusetts General Hospital

Clinical Hurdles of Pluripotent Stem Cell Therapy
Joseph C. Wu, M.D., Ph.D.external link icon
Stanford University School of Medicine

Enhancing Stem Cell Regenerative Potential in Aging and Transplantation
Amy Wagers, Ph.D.external link icon
Joslin Diabetes Center and Harvard University

Induced Pluripotent Stem Cell-based Disease Modeling and Small Molecule Screening
   Reveal Modulators of Intracellular Lipid Metabolism

Sean M. Wu, M.D., Ph.D.external link icon
Massachusetts General Hospital and Harvard Medical School

Human Embryonic Stem Cell-derived Cardiomyocytes for Heart Disease: In Vitro
   Characterization and Pre-clinical Results

Joseph Gold, Ph.D.external link icon
Geron Corporation

 

Questions and Answers

10:15 a.m.

Break

10:45 a.m. - 12:40 p.m.

Session V: Tissue Engineering
Moderator: W. Robb MacLellan, M.D.
                 University of California, Los Angeles, School of Medicine

Towards a Tissue Engineered Heart: The Sum Will Be Harder Than the Parts
Kevin Kit Parker, Ph.D.
Harvard University

First Human use of an Allogeneic, Tissue Engineered Vascular Graft
Todd McAllister, Ph.D.external link icon
St. Joseph's Translational Research Inistute and Cytograft Tissue and Engineering, Inc.

Myocardial Regeneration Through Tissue Engineering
Gordana Vunjak-Novakovic, Ph.D.external link icon
Columbia University

Highly Functional Stem Cell-derived Cardiac Tissues
Nenad Bursac, Ph.D.external link icon
Duke University

 

Questions and Answers

12:40 p.m.

Lunch

1:40 - 3:35 p.m.

Session VI: Update on NHLBI Progenitor Consortium
Moderator: Denis B. Buxton, Ph.D.
                 National Heart, Lung, and Blood Institute

Stem Cell Approaches To Understand Lung Injury Repair and Lung Cancers
Carla Kim, Ph.D.external link icon
Children’s Hospital Boston and Harvard Medical School

An ES/iPS Cell Strategy for Platelet Transfusions
Mortimer Poncz, M.D.external link icon
The Children’s Hospital of Philadelphia

Optimizing Cardiovascular Stem Cells for Cardiac Repair and Regeneration
Antonis Hatzopoulos, Ph.D.external link icon
Vanderbilt University

Epigenetic State and Genetic Stability of Human iPS Cells
James A. Thomson, V.M.D., Ph.D.external link icon
Morgridge Institute for Research and University of Wisconsin

 

Questions and Answers

3:35 - 4:50 p.m.

Session VII: Clinical Trials Update/Roundtable: Are we Ready for the Next Generation of Stem Cell-related Therapy?
Moderators: Jason C. Kovacic, M.D., Ph.D., F.A.C.C.
                   Mount Sinai Hospital

                   Sonia Skarlatos, Ph.D.
                   National Heart, Lung, and Blood Institute

Cardiosphere-derived Cells for Heart Regeneration: Proof of Concept in Humans
Eduardo Marbán, M.D., Ph.D.external link icon
Cedars-Sinai Medical Center

Progress and Perspectives From the NHLBI-sponsored Cardiovascular Cell Therapy
   Research Network

Robert D. Simari, M.D.external link icon
Mayo Clinic

Cell-based Therapy for Cardiac Repair: From Concept to Clinic
Joshua M. Hare, M.D.external link icon
University of Miami

Autologous CD34+ Cell Therapy for Ischemic Tissue Repair: Human Clinical Experience
Douglas W. Losordo, M.D.external link icon
Northwestern University/Northwestern Memorial Hospital

The BOOST Translational Study Program
Kai C. Wollert, M.D.
Hannover Medical School (Germany)

4:50 p.m.

Closing Remarks and Adjournment
Manfred Boehm, M.D.
National Heart, Lung, and Blood Institute


View Tuesday October 4 Agenda




Last Updated July 27, 2011




Twitter iconTwitterExternal link Disclaimer         Facebook iconFacebookimage of external link icon         YouTube iconYouTubeimage of external link icon         Google+ iconGoogle+image of external link icon